EDIT - Financial Reports List - Editas Medicine, Inc. - IntrinsicAlpha

Editas Medicine, Inc. EDIT

Healthcare - Biotechnology - NASDAQ - US

$ 1.56

3.91 %

$ 131 M

Market Cap

-0.46

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-49.03%	-140.52%	-94.45%
Annual Report	FY	10-K	2024-12-31	-58.64%	-54.74%	-48.45%
Quarterly Report	Q3	8-K	2024-09-30	-98.86%	-38.03%	-45.86%
Quarterly Report	Q2	8-K	2024-06-30	-82.23%	-67.80%	-63.07%
Quarterly Report	Q1	8-K	2024-03-31	-88.48%	-35.95%	-31.46%
Quarterly Report	Q4	8-K	2023-12-31	818.74%	65.70%	62.23%
Annual Report	FY	10-K	2023-12-31	296.32%	25.02%	25.12%
Quarterly Report	Q3	8-K	2023-09-30	12604.76%	16.53%	21.73%
Quarterly Report	Q2	8-K	2023-06-30	-54.62%	23.51%	18.70%
Quarterly Report	Q1	8-K	2023-03-31	45.49%	9.37%	-0.42%

1